Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Julien M. Buyck"'
Autor:
Olivier Cunrath, Dominik M. Meinel, Pauline Maturana, Joseph Fanous, Julien M. Buyck, Pamela Saint Auguste, Helena M.B. Seth-Smith, Jonas Körner, Christoph Dehio, Vincent Trebosc, Christian Kemmer, Richard Neher, Adrian Egli, Dirk Bumann
Publikováno v:
EBioMedicine, Vol 41, Iss , Pp 479-487 (2019)
Background: Efflux pumps mediate antimicrobial resistance in several WHO critical priority bacterial pathogens. However, most available data come from laboratory strains. The quantitative relevance of efflux in more relevant clinical isolates remains
Externí odkaz:
https://doaj.org/article/83adf038018a43549d6ed8f1a82d4214
Autor:
Chantal Valcourt, Julien M. Buyck, Nicolas Grégoire, William Couet, Sandrine Marchand, Frédéric Tewes
Publikováno v:
Pharmaceutics, Vol 13, Iss 11, p 1849 (2021)
Resistance to colistin, one of the antibiotics of last resort against multidrug-resistant Gram-negative bacteria, is increasingly reported. Notably, MCR plasmids discovered in 2015 have now been reported worldwide in humans. To keep this antibiotic o
Externí odkaz:
https://doaj.org/article/e8b2dfe394c14a4ab6a8c815ea2c8b93
Autor:
Phong Thi Nam Nguyen, Julien M. Buyck, Stephen Baker, Trang Hoang Thu Nguyen, Tin Viet Pham, Do Thi Hong Tuoi
Publikováno v:
MedPharmRes. 6:34-42
Introduction: Streptococcus pneumoniae is the most common cause of community-acquired pneumonia (CAP) in children. Recently, the rapid emergence of antibiotic-resistant pneumococci has posed enormous challenges for CAP treatment and public health. Th
Autor:
Alexia Chauzy, Grace Akrong, Vincent Aranzana-Climent, Jérémy Moreau, Laure Prouvensier, Hélène Mirfendereski, Julien M Buyck, William Couet, Sandrine Marchand
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Frontiers, 2022, 13, ⟨10.3389/fphar.2022.842921⟩
Frontiers in Pharmacology, Frontiers, 2022, 13, ⟨10.3389/fphar.2022.842921⟩
The reduction in antimicrobial activity at high bacterial counts is a microbiological phenomenon known as the inoculum effect (IE). In a previous in vitro study, a significant IE was observed for polymyxin B (PMB) against a clinical isolate of Acinet
Autor:
Sandrine Marchand, Vincent Aranzana-Climent, Julien M. Buyck, Mathilde Lacroix, Laure Prouvensier, William Couet, Alexia Chauzy, Grace Akrong, Luc Deroche
Publikováno v:
Antimicrob Agents Chemother
The inoculum effect (i.e., reduction in antimicrobial activity at large starting inoculum) is a phenomenon described for various pathogens. Given that limited data exist regarding inoculum effect of Acinetobacter baumannii, we evaluated killing of A.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f6c2c83f7ef1787e7f4ec41afdda0ce
https://europepmc.org/articles/PMC8765416/
https://europepmc.org/articles/PMC8765416/
Autor:
Alexia, Chauzy, Grace, Akrong, Vincent, Aranzana-Climent, Jérémy, Moreau, Laure, Prouvensier, Hélène, Mirfendereski, Julien M, Buyck, William, Couet, Sandrine, Marchand
Publikováno v:
Frontiers in pharmacology. 13
The reduction in antimicrobial activity at high bacterial counts is a microbiological phenomenon known as the inoculum effect (IE). In a previous
Autor:
Frederic Tewes, Chantal Valcourt, Sandrine Marchand, William Couet, Julien M. Buyck, Nicolas Grégoire
Publikováno v:
Pharmaceutics
Pharmaceutics, MDPI, 2021, 13 (11), pp.1849. ⟨10.3390/pharmaceutics13111849⟩
Volume 13
Issue 11
Pharmaceutics, Vol 13, Iss 1849, p 1849 (2021)
Pharmaceutics, MDPI, 2021, 13 (11), pp.1849. ⟨10.3390/pharmaceutics13111849⟩
Volume 13
Issue 11
Pharmaceutics, Vol 13, Iss 1849, p 1849 (2021)
Resistance to colistin, one of the antibiotics of last resort against multidrug-resistant Gram-negative bacteria, is increasingly reported. Notably, MCR plasmids discovered in 2015 have now been reported worldwide in humans. To keep this antibiotic o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8027f44c5f238a35f299402c1121bed6
https://hal.archives-ouvertes.fr/hal-03626643
https://hal.archives-ouvertes.fr/hal-03626643
Autor:
Frédéric, Peyrusson, Tiep K, Nguyen, Julien M, Buyck, Sandrine, Lemaire, Gang, Wang, Cristina, Seral, Paul M, Tulkens, Françoise, Van Bambeke
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2357
Intracellular bacteria are poorly responsive to antibiotic treatment. Pharmacological studies are thus needed to determine the antibiotics which are the most potent or effective against intracellular bacteria as well as to explore the reasons for poo
Autor:
Christian Schleberger, Joseph Fanous, Sandra Söderholm, Adrian Egli, Johanna Ude, Olivier Cunrath, Dirk Bumann, Beatrice Claudi, Vishwachi Tripathi, Julien M. Buyck, Sebastian Hiller
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2021, 118 (31), ⟨10.1073/pnas.2107644118⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2021, 118 (31), ⟨10.1073/pnas.2107644118⟩
International audience; Gram-negative bacterial pathogens have an outer membrane that restricts entry of molecules into the cell. Water-filled protein channels in the outer membrane, so-called porins, facilitate nutrient uptake and are thought to ena
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57ba07578fd84ed4fa37078e29766610
Autor:
William Couet, Sandrine Marchand, Blandine Rammaert, Julien M. Buyck, Nicolas Grégoire, Alexia Chauzy
Publikováno v:
Clinical Pharmacokinetics
Clinical Pharmacokinetics, Springer Verlag, 2020, ⟨10.1007/s40262-020-00968-x⟩
Clinical Pharmacokinetics, Springer Verlag, 2020, ⟨10.1007/s40262-020-00968-x⟩
International audience; Due to the low level of resistance observed with daptomycin, this antibiotic has an important place in the treatment of severe Gram-positive infections. It is the first-in-class of the group of calcium-dependent, membrane-bind